(2022) 2022 Alzheimer’s disease facts and figures. Alzheimers Dement. 18:700–789
Frise´n CBJ J, Lothian C, Lendahl U (1998) Central nervous system stem cells in the embryo and adult. CMLS Cell Mol Life Sci 54:9
Joo HJ, Moon Y, Jung JH (2024) Variability of relationship between inner-retinal structural changes and visual dysfunction in optic neuropathy. Sci Rep 14:12069
Article PubMed PubMed Central Google Scholar
Gupta VB, Chitranshi N, den Haan J, Mirzaei M, You Y, Lim JK et al (2021) Retinal changes in Alzheimer’s disease- integrated prospects of imaging, functional and molecular advances. Prog Retin Eye Res 82:100899
Chan VTT, Sun Z, Tang S, Chen LJ, Wong A, Tham CC et al (2019) Spectral-Domain OCT measurements in Alzheimer’s disease: a systematic review and Meta-analysis. Ophthalmology 126:497–510
Ito Y, Sasaki M, Takahashi H, Nozaki S, Matsuguma S, Motomura K et al (2020) Quantitative assessment of the retina using OCT and associations with cognitive function. Ophthalmology 127:107–118
den Haan J, van de Kreeke JA, Konijnenberg E, ten Kate M, den Braber A, Barkhof F et al (2019) Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer’s disease. Alzheimers Dement (Amst) 11:463–471
Sanchez D, Castilla-Marti M, Marquie M, Valero S, Moreno-Grau S, Rodriguez-Gomez O et al (2020) Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer’s disease in a memory clinic. Sci Rep 10:1580
Article PubMed PubMed Central Google Scholar
Ning A, Cui J, To E, Ashe KH, Matsubara J (2008) Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci 49:5136–5143
Xie J, Yi Q, Wu Y, Zheng Y, Liu Y, Macerollo A et al (2024) Deep segmentation of OCTA for evaluation and association of changes of retinal microvasculature with Alzheimer’s disease and mild cognitive impairment. Br J Ophthalmol 108:432–439
Sáez ME, García-Sánchez A, de Rojas I, Alarcón-Martín E, Martínez J, Cano A et al (2024) Genome-wide association study and polygenic risk scores of retinal thickness across the cognitive continuum: data from the NORFACE cohort. Alzheimers Res Ther 16:38
Article PubMed PubMed Central Google Scholar
Emdin CA, Khera AV, Kathiresan S (2017) Mendelian Randomization. JAMA 318:19
Currant H, Hysi P, Fitzgerald TW, Gharahkhani P, Bonnemaijer PWM, Senabouth A et al (2021) Genetic variation affects morphological retinal phenotypes extracted from UK Biobank optical coherence tomography images. PLoS Genet 17:e1009497
Article PubMed PubMed Central Google Scholar
Sarnowski C, Ghanbari M, Bis JC, Logue M, Fornage M, Mishra A et al (2022) Meta-analysis of genome-wide association studies identifies ancestry-specific associations underlying circulating total Tau levels. Commun Biol 5:336
Article PubMed PubMed Central Google Scholar
Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC et al (2019) Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet 51:414–430
Article PubMed PubMed Central Google Scholar
Bellenguez C, Kucukali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N et al (2022) New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nat Genet 54:412–436
Article PubMed PubMed Central Google Scholar
Li R, Peng L, Deng D, Li G, Wu S (2024) Causal relationship between Alzheimer’s disease and prostate cancer: a bidirectional Mendelian randomization analysis. Front Endocrinol (Lausanne) 15:1354528
Li R, Huang G, Li Y, Huang M, Huang Y, Li Y et al (2024) Assessing the role of statin therapy in bladder cancer: evidence from a Mendelian randomization study. Front Pharmacol 15:1427318
Article PubMed PubMed Central Google Scholar
Carter AR, Sanderson E, Hammerton G, Richmond RC, Davey Smith G, Heron J et al (2021) Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur J Epidemiol 36:465–478
Article PubMed PubMed Central Google Scholar
Ference BA (2015) Mendelian randomization studies: using naturally randomized genetic data to fill evidence gaps. Curr Opin Lipidol 26:566–571
Burgess S, Thompson SG (2017) Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol 32:377–389
Article PubMed PubMed Central Google Scholar
Zuber V, Grinberg NF, Gill D, Manipur I, Slob EAW, Patel A et al (2022) Combining evidence from Mendelian randomization and colocalization: review and comparison of approaches. Am J Hum Genet 109:767–782
Article PubMed PubMed Central Google Scholar
Hu J, Lu J, Lu Q, Weng W, Guan Z, Wang Z (2023) Mendelian randomization and colocalization analyses reveal an association between short sleep duration or morning chronotype and altered leukocyte telomere length. Commun Biol 6:1014
Article PubMed PubMed Central Google Scholar
Mutlu U, Colijn JM, Ikram MA, Bonnemaijer PWM, Licher S, Wolters FJ et al (2018) Association of retinal neurodegeneration on optical coherence tomography with dementia: a population-based study. JAMA Neurol 75:1256–1263
Article PubMed PubMed Central Google Scholar
Ko F, Muthy ZA, Gallacher J, Sudlow C, Rees G, Yang Q et al (2018) Association of retinal nerve fiber layer thinning with current and future cognitive decline: a study using optical coherence tomography. JAMA Neurol 75:1198–1205
Article PubMed PubMed Central Google Scholar
Asanad S, Ross-Cisneros FN, Nassisi M, Barron E, Karanjia R, Sadun AA (2019) The retina in Alzheimer’s disease: histomorphometric analysis of an ophthalmologic biomarker. Invest Ophthalmol Vis Sci. https://doi.org/10.1167/iovs.18-25966
Article PubMed PubMed Central Google Scholar
Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Miller CA, Ko MK, Black KL et al (2011) Identification of amyloid plaques in retinas from Alzheimer’s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. NeuroImage 54(Suppl 1):S204–217
Tatham AJ, Medeiros FA (2017) Detecting structural progression in glaucoma with optical coherence tomography. Ophthalmology 124:S57–S65
Chrysou A, Jansonius NM, van Laar T (2019) Retinal layers in Parkinson’s disease: a meta-analysis of spectral-domain optical coherence tomography studies. Parkinsonism Relat Disord 64:40–49
Ma X, Wang Y, Wang N, Zhang R (2021) Retina thickness in atypical parkinsonism: a systematic review and meta-analysis. J Neurol 269:1272–1281
Moreno-Ramos T, Benito-León J, Villarejo A, Bermejo-Pareja F (2013) Retinal nerve fiber layer thinning in dementia associated with parkinson’s disease, dementia with lewy bodies, and Alzheimer’s disease. J Alzheimers Dis 34:659–664
Yin GS, van der Heide F, Littlejohns TJ, Kuźma E, Hayat S, Brayne C et al (2023) Association between retinal nerve fiber layer thickness and incident dementia in the European Prospective Investigation into Cancer in Norfolk Cohort. J Alzheimers Dis 95:691–702
van Koolwijk LME, Despriet DDG, Van Duijn CM, Oostra BA, van Swieten JC, de Koning I et al (2009) Association of cognitive functioning with retinal nerve fiber layer thickness. Invest Ophthalmol Vis Sci 50:4576–4580
van de Kreeke JA, Nguyen HT, den Haan J, Konijnenberg E, Tomassen J, den Braber A et al (2019) Retinal layer thickness in preclinical Alzheimer’s disease. Acta Ophthalmol 97:798–804
Comments (0)